Cargando…
Clinical outcomes meta-analysis: measuring subendocardial perfusion and efficacy of transmyocardial laser revascularization with nuclear imaging
INTRODUCTION: Randomized and nonrandomized clinical trials have tried to assess whether or not TMR patients experience an increase in myocardial perfusion. However there have been inconsistencies reported in the literature due to the use of different nuclear imaging modalities to test this metric. T...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5438520/ https://www.ncbi.nlm.nih.gov/pubmed/28526044 http://dx.doi.org/10.1186/s13019-017-0602-8 |
_version_ | 1783237780304822272 |
---|---|
author | Iwanski, Jessika Knapp, Shannon M. Avery, Ryan Oliva, Isabel Wong, Raymond K. Runyan, Raymond B. Khalpey, Zain |
author_facet | Iwanski, Jessika Knapp, Shannon M. Avery, Ryan Oliva, Isabel Wong, Raymond K. Runyan, Raymond B. Khalpey, Zain |
author_sort | Iwanski, Jessika |
collection | PubMed |
description | INTRODUCTION: Randomized and nonrandomized clinical trials have tried to assess whether or not TMR patients experience an increase in myocardial perfusion. However there have been inconsistencies reported in the literature due to the use of different nuclear imaging modalities to test this metric. The primary purpose of this meta-analysis was to determine whether SPECT, MUGA and PET scans demonstrate changes in myocardial perfusion between lased and non-lased subjects and whether laser type affects myocardial perfusion. The secondary purpose was to examine the overall effect of laser therapy on clinical outcomes including survival, hospital re-admission and angina reduction. METHODS: Sixteen studies were included in the primary endpoint analysis after excluding all other non-imaging TMR papers. Standardized mean difference was used as the effect size for all quantitative outcomes and log odds ratio was used as the effect size for all binary outcomes. RESULTS: Statistically significant improvements in myocardial perfusion were observed between control and treatment groups in myocardial perfusion at 6-month follow up using PET imaging with a porcine model. However non-significant differences were observed in patients at 3 and 12 months using SPECT, PET or MUGA scans. Both CO(2) and Ho:YAG laser systems demonstrated an increase in myocardial perfusion however this effect was not statistically significant. In addition both laser types displayed statistically significant decreases in patient angina at 3, 6 and 12 months but non-significant increases in survival rates and decreases in hospital re-admissions. CONCLUSION: In order to properly assess myocardial perfusion in TMR subjects, subendocardial perfusion needs to be analyzed via nuclear imaging. PET scans can provide this level of sensitivity and should be utilized in future studies to monitor and detect perfusion changes in lased and non-lased subjects. |
format | Online Article Text |
id | pubmed-5438520 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-54385202017-05-22 Clinical outcomes meta-analysis: measuring subendocardial perfusion and efficacy of transmyocardial laser revascularization with nuclear imaging Iwanski, Jessika Knapp, Shannon M. Avery, Ryan Oliva, Isabel Wong, Raymond K. Runyan, Raymond B. Khalpey, Zain J Cardiothorac Surg Review INTRODUCTION: Randomized and nonrandomized clinical trials have tried to assess whether or not TMR patients experience an increase in myocardial perfusion. However there have been inconsistencies reported in the literature due to the use of different nuclear imaging modalities to test this metric. The primary purpose of this meta-analysis was to determine whether SPECT, MUGA and PET scans demonstrate changes in myocardial perfusion between lased and non-lased subjects and whether laser type affects myocardial perfusion. The secondary purpose was to examine the overall effect of laser therapy on clinical outcomes including survival, hospital re-admission and angina reduction. METHODS: Sixteen studies were included in the primary endpoint analysis after excluding all other non-imaging TMR papers. Standardized mean difference was used as the effect size for all quantitative outcomes and log odds ratio was used as the effect size for all binary outcomes. RESULTS: Statistically significant improvements in myocardial perfusion were observed between control and treatment groups in myocardial perfusion at 6-month follow up using PET imaging with a porcine model. However non-significant differences were observed in patients at 3 and 12 months using SPECT, PET or MUGA scans. Both CO(2) and Ho:YAG laser systems demonstrated an increase in myocardial perfusion however this effect was not statistically significant. In addition both laser types displayed statistically significant decreases in patient angina at 3, 6 and 12 months but non-significant increases in survival rates and decreases in hospital re-admissions. CONCLUSION: In order to properly assess myocardial perfusion in TMR subjects, subendocardial perfusion needs to be analyzed via nuclear imaging. PET scans can provide this level of sensitivity and should be utilized in future studies to monitor and detect perfusion changes in lased and non-lased subjects. BioMed Central 2017-05-19 /pmc/articles/PMC5438520/ /pubmed/28526044 http://dx.doi.org/10.1186/s13019-017-0602-8 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Review Iwanski, Jessika Knapp, Shannon M. Avery, Ryan Oliva, Isabel Wong, Raymond K. Runyan, Raymond B. Khalpey, Zain Clinical outcomes meta-analysis: measuring subendocardial perfusion and efficacy of transmyocardial laser revascularization with nuclear imaging |
title | Clinical outcomes meta-analysis: measuring subendocardial perfusion and efficacy of transmyocardial laser revascularization with nuclear imaging |
title_full | Clinical outcomes meta-analysis: measuring subendocardial perfusion and efficacy of transmyocardial laser revascularization with nuclear imaging |
title_fullStr | Clinical outcomes meta-analysis: measuring subendocardial perfusion and efficacy of transmyocardial laser revascularization with nuclear imaging |
title_full_unstemmed | Clinical outcomes meta-analysis: measuring subendocardial perfusion and efficacy of transmyocardial laser revascularization with nuclear imaging |
title_short | Clinical outcomes meta-analysis: measuring subendocardial perfusion and efficacy of transmyocardial laser revascularization with nuclear imaging |
title_sort | clinical outcomes meta-analysis: measuring subendocardial perfusion and efficacy of transmyocardial laser revascularization with nuclear imaging |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5438520/ https://www.ncbi.nlm.nih.gov/pubmed/28526044 http://dx.doi.org/10.1186/s13019-017-0602-8 |
work_keys_str_mv | AT iwanskijessika clinicaloutcomesmetaanalysismeasuringsubendocardialperfusionandefficacyoftransmyocardiallaserrevascularizationwithnuclearimaging AT knappshannonm clinicaloutcomesmetaanalysismeasuringsubendocardialperfusionandefficacyoftransmyocardiallaserrevascularizationwithnuclearimaging AT averyryan clinicaloutcomesmetaanalysismeasuringsubendocardialperfusionandefficacyoftransmyocardiallaserrevascularizationwithnuclearimaging AT olivaisabel clinicaloutcomesmetaanalysismeasuringsubendocardialperfusionandefficacyoftransmyocardiallaserrevascularizationwithnuclearimaging AT wongraymondk clinicaloutcomesmetaanalysismeasuringsubendocardialperfusionandefficacyoftransmyocardiallaserrevascularizationwithnuclearimaging AT runyanraymondb clinicaloutcomesmetaanalysismeasuringsubendocardialperfusionandefficacyoftransmyocardiallaserrevascularizationwithnuclearimaging AT khalpeyzain clinicaloutcomesmetaanalysismeasuringsubendocardialperfusionandefficacyoftransmyocardiallaserrevascularizationwithnuclearimaging |